相关实验视频
Updated: Jan 13, 2026

07:56
Protocol for Long Duration Whole Body Hyperthermia in Mice
Published on: August 25, 2012
12.0K
超热体外应用瘤治疗 (HEATT®) 在临终关怀资格的癌症患者中
Joseph B Zwischenberger1, Peyton Mashni2, Robert Fischer3
1Department of Surgery, University of Kentucky, Lexington, KY, USA.
Perfusion
|January 8, 2026
概括
超热体外应用瘤治疗 (HEATT®) 安全地延长了临终关怀资格的晚期癌症患者的生存期. 13名患者中有8人活得比预期更长,其中5人活了12-18个月.
科学领域:
- 在瘤学瘤学.
- 医疗器械 医疗器械
- 临床研究 临床研究
背景情况:
- 在之前的研究中,在42°C的静脉输液诱导的全身高温 (VV-PISH) 显示了癌细胞死亡的潜力.
- VV-PISH电路得到了改进,并重新命名为高热体外应用瘤治疗 (HEATT®).
研究的目的:
- 评估 HEATT® 精制疗法的安全性和有效性,对患有晚期,不反应的癌症,符合住院条件的患者进行评估.
- 改进HEATT®的包括/排除标准和 perfusion 技术,以改善患者的治疗结果.
主要方法:
- 对13名接受单次HEATT®治疗 (42°C120分钟) 的临终关怀资格的患者进行了回顾性图表审查.
- 患者是通过转诊医生来选择的,这些医生符合临终关怀的条件,预计平均存活时间为3个月.
- 该研究涉及一支一致的医疗保健团队和FDA批准的设备.
主要成果:
- 在13名患者中,有8人超过了预期的中位生存期.
- 在13名患者中,有6名患者超过预测的6个月生存期.
- 在13名患者中,5名患者存活了12至18个月,比预期的要长得多.
结论:
- 在一小群晚期癌症患者中,精制的HEATT®治疗证明了安全性和增加生存的潜力.
- 输液技术和选择标准的改进 (卡诺夫斯基>70,行走,年龄<80) 加强了标准化.
- 建议进行进一步的前性随机试验,以在类似患者群体中建立基于证据的HEATT®推.
相关概念视频
Decreased Body Temperature
994
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
994
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Increased Body Temperature
6.4K
A body temperature above 38°C (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
6.4K
Homeostatic Imbalances in Body Temperature
4.3K
Hyperthermia occurs when the body's temperature becomes unusually high, often due to heat exposure, intense physical activity, or certain illnesses. This condition can create a dangerous cycle where elevated body temperature increases the metabolic rate, generating more heat and potentially leading to organ failure and brain damage. A severe form of hyperthermia, called heat stroke, can raise body temperature to life-threatening levels. Fever, on the other hand, is a controlled form of...
4.3K
Continuing Care
1.9K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.9K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K

